Escitalopram Oxalate 5mg Tablet Franchise in Ahmedabad

Antidepressant Tablet Supplier in Bangalore

Escitalopram Tablet Distributor in Hyderabad

Anxiety & Depression Tablet Franchise Opportunity in Jaipur

Psychiatric Medicine Tablet Stockist in Mumbai
Escitalopram Tablet Export & Manufacturing in Chandigarh

Home/Products /escitalopram-oxalate-5mg-tablet

Escitale 5 Tablet

Composition : Escitalopram Oxalate (5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Escitale 5 Tablet contains Escitalopram Oxalate 5mg, a mild-strength SSRI used to treat mild depression, generalized anxiety disorder, and panic disorder. It enhances serotonin levels in the brain, helping stabilize mood and relieve early symptoms of depression and anxiety.

The 5mg dosage is ideal for initiating therapy, dose titration, and for patients sensitive to higher doses. It provides a safe and effective start to antidepressant treatment while minimizing side effects.

For hospitals, clinics, and pharmaceutical distributors, Escitale 5 Tablet is a highly prescribed antidepressant, frequently used in outpatient psychiatry departments, counseling centers, and mental health clinics. Its consistent demand ensures steady orders and reliable market movement.

Adding Escitale 5 Tablet to your portfolio strengthens your mental health and psychiatric segment, offering opportunities in hospital procurement, pharmacy distribution, institutional tenders, export markets, and third-party manufacturing. Its clinical utility and patient-friendly dosage make it a valuable addition for pharmaceutical distributors.

Read More

About the Product

Escitale 5 Tablet contains Escitalopram Oxalate 5mg, a mild-strength SSRI used to treat mild depression, generalized anxiety disorder, and panic disorder. It enhances serotonin levels in the brain, helping stabilize mood and relieve early symptoms of depression and anxiety.

The 5mg dosage is ideal for initiating therapy, dose titration, and for patients sensitive to higher doses. It provides a safe and effective start to antidepressant treatment while minimizing side effects.

For hospitals, clinics, and pharmaceutical distributors, Escitale 5 Tablet is a highly prescribed antidepressant, frequently used in outpatient psychiatry departments, counseling centers, and mental health clinics. Its consistent demand ensures steady orders and reliable market movement.

Adding Escitale 5 Tablet to your portfolio strengthens your mental health and psychiatric segment, offering opportunities in hospital procurement, pharmacy distribution, institutional tenders, export markets, and third-party manufacturing. Its clinical utility and patient-friendly dosage make it a valuable addition for pharmaceutical distributors.

Some patients may experience nausea, headache, dizziness, insomnia, dry mouth, or mild gastrointestinal discomfort. Rarely, serotonin syndrome, severe allergic reactions, or suicidal thoughts may occur, especially in younger adults.

Escitale 5 Tablet is indicated for the treatment of depression, generalized anxiety disorder (GAD), panic disorder, and other serotonin-related conditions. It aids in alleviating low mood, anxiety, and stress-related symptoms.

Use under strict medical supervision. Do not discontinue therapy abruptly without consulting a doctor. Avoid in patients with hypersensitivity to Escitalopram or other SSRIs. Regularly monitor mood and behavior during treatment.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation